| 1. |
- Bolin, Karin, 1982-, et al.
(författare)
-
Variants in BANK1 are associated with lupus nephritis
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- Background: Lupus nephritis (LN) is a cause of significant morbidity in SLE. While the genetic background to SLE has been well characterized, less is known about genes predisposing to LN.Methods: The study consisted of 2886 SLE patients, including 947 (33%) with LN. The discovery cohort (Sweden, n=1091) and replication cohort 1 (US, n=962) were genotyped on the Immunochip and replication cohort 2 (Norway/Denmark, n=833) on a custom array chip. Allele frequencies were compared between patients with LN, proliferative nephritis, end-stage renal disease and LN negative patients. SNPs with p-value <0.001 in the discovery cohort were analyzed in replication cohort 1. Ten SNPs associated with LN in the discovery cohort (p<0.0002) were genotyped in replication cohort 2. DNA methylation data were available for 180 LN patients from the discovery cohort.Results: In the discovery cohort, six gene loci were associated with LN (p<1x10-4, NFKBIA, CACNA1S, ITGA1, BANK1, OR2Y and PHCA). SNPs in BANK1 showed the strongest association with LN in replication cohort 1 (p=9.5x10-4), with a tendency for an association in replication cohort 2 (p=0.052). In a meta-analysis of all three cohorts the association between LN and BANK1 rs4699259, was strengthened (p=1.7x10‑7). There were no associations to proliferative nephritis or ESRD in the meta-analysis. Methylation quantitative trait loci (MeQTL) effects between a CpG site and several SNPs in BANK1 were identified.Conclusion: Genetic variations in BANK1 are associated with LN. There is evidence for genetic regulation of DNA methylation within the BANK1 locus, however, the exact role of BANK1 in LN pathogenesis remains to be elucidated.
|
|
| 2. |
- Jönsen, Andreas
(författare)
-
Studies on Neuropsychiatric Manifestations and Genetic Factors in Systemic Lupus Erythematosus
- 2006
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease encompassing a wide range of symptoms that can emanate from pathology in virtually any organ system. Severe SLE includes involvement of the central nervous system and kidneys. One of the hallmarks of the disease is a multitude of autoantibodies, indicating a breakdown in self tolerance. The corresponding antigens have been found to be exposed in cells undergoing apoptosis. Increased rate of apoptosis and an impaired clearance machinery for apoptotic material leading to secondary necrosis have been put forward as potential mechanisms by which a genetically prone individual develop an immune response to self antigens. Inherent dysregulation of tolerance and the immune response augment and perpetuate the situation generating autoreactive B- and T-cells, which together with autoantibodies and immune complexes mediate tissue inflammation with subsequent development of clinical symptoms. In this thesis, studies on neuropsychiatric involvement in SLE (NPSLE) and the genetic contribution to susceptibility and phenotypic expression of SLE are presented. Results: In paper I, an association was seen between NPSLE and worse prognosis measured as working incapacity and extent of organ damage, but not with increased mortality, as compared to non-NPSLE patients. In paper II, the conclusion is drawn that cerebrospinal fluid analyses of cytokines and autoantibodies may be of limited value in NPSLE diagnosis, while increased concentrations of anti-ribosomal P protein antibodies in serum could constitute a marker for SLE psychosis. In paper III, polymorphic variants of genes with well-documented roles in different parts of SLE pathogenesis were studied with the hypothesis that gene variant combinations could be informative regarding susceptibility for and pathogenesis in SLE. The extended haplotype HLA DR3-DQ2-C4AQ0 was more common in SLE patients than in controls (p<0.01). Furthermore, an increased prevalence of the combination of the IL-1 Ra 2/2 and the Fc?RIIa R/R genotypes was found in SLE patients compared to healthy controls (p<0.01). In paper IV, several genetic variants were found to influence disease phenotype. Thus, presence of a CRP4 A-allele was associated with SLE nephritis (p<0.01) and inversely correlated with arthritis (p<0.01). Furthermore, the Fc?RIIIa F/F genotype correlated with WHO class III and IV nephritis. Presence of anti-dsDNA or anti-C1q antibodies did not have an additional impact on the genetic susceptibility to nephritis. Additionally, the Fc?RIIIb NA2/NA2 genotype was associated with butterfly rash (p<0.01). Combinations of genotypes revealed an association between seizures and the presence of both the Fc?RIIa R/R and the Fc?RIIIa F/F genotypes (p<0.01), as well as an inverse correlation between serositis and the CRP4 A-allele when present together with the IL-1Ra 2-allele. In paper V, the impact of deficiency in the complement protein mannan-binding lectin (MBL) on cerebrovascular, cardiovascular and peripheral arterial organ damage (CPAD) and severe infections was studied. In a multiple logistic regression model smoking (p=0.001), hypertension (p=0.03), alcohol intake (p=0.027) and serum triglyceride concentrations (p=0.026) were associated with CPAD, while MBL deficiency did not reach significance (p=0.098). Alcohol intake (>15 g/month) was inversely correlated with CPAD (OR=0.29, 95%CI 0.096-0.87). Pneumonia and severe infections were not more common in SLE patients with MBL deficiency. There was a significant association between treatment with high-dose glukocorticoids and presence of severe infections (p=0.008). Treatment with cytostatic drugs was also more common in patients with these severe infections, but the correlation did not reach statistical significance (p=0.054). Conclusions: Neuropsychiatric involvement is a severe manifestation of SLE, but is heterogeneous and diagnostic tests in CSF are of limited value. Combination of genetic variants can be of importance in determining SLE susceptibility and the contribution of polymorphic genes to disease phenotype is substantial.
|
|
| 3. |
- Reid, Sarah, et al.
(författare)
-
From genetic predisposition to clinical outcome in systemic lupus erythematosus : construction and validation of sub-phenotype-specific genetic risk scores
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- ObjectiveThis study aimed to link known genetic risk factors for systemic lupus erythematosus (SLE) with specific clinical manifestations of the disease, in both a large biobank population and in a clinical cohort of patients with SLE.MethodsScandinavian patients with SLE (n=1487) who fulfilled ≥4 ACR-82/ACR-97/SLICC-2012 classification criteria, were genotyped using the Immunochip or Global Screening array (Illumina). Clinical data was collected from medical records. Summary statistics for 57 established SLE risk SNPs (p<5×10-8 in the European population) with a validated cumulative effect on disease severity in SLE, was retrieved for 30 FinnGen datasets covering manifestations relevant for SLE. Mendelian randomization (MR) analysis was performed using the inverse variance weighed method. Nine datasets were selected for construction of standardized genetic risk scores (GRSs), which were validated in the clinical cohort using gender- and disease duration-adjusted logistic regression.ResultsIn the FinnGen biobank, the cumulative effect of the 57 SLE risk SNPs was associated with an increased risk of rosacea, OR 1.09 (1.03–1.16), polyarthropathies, OR 1.10 (1.06–1.14), pleural effusions, OR 1.09 (1.04–1.14)) and hemolytic anemia, OR 1.32 (1.10–1.58). In the clinical cohort, the GRSs generated from the FinnGen datasets were associated with their corresponding manifestation for arthritis, OR 1.15 (1.02– 1.31), renal disorder, OR 1.15 (1.04–1.29), neurologic disorder, OR 1.24 (1.04–1.47), hematologic disorder, OR 1.12 (1.00–1.24), and immunologic disorder, OR 1.37 (1.22–1.56).ConclusionBy considering associations of SLE risk SNPs with SLE-like manifestations in the FinnGen biobank, construction and validation of GRSs for five of the eleven ACR-82 criteria was possible. The findings may facilitate personalized risk prediction and targeted intervention strategies for patients with SLE.
|
|
| 4. |
- Reid, Sarah, et al.
(författare)
-
High Genetic Risk Score Is Associated with Increased Organ Damage in SLE
- 2017
-
Ingår i: Arthritis & Rheumatology. - : John Wiley & Sons. - 2326-5191 .- 2326-5205. ; 69
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease with a complex genetic etiology. Over 80 risk genes for SLE have been identified and some genetic variants have demonstrated association with specific disease manifestations, such as STAT4 and nephritis. The overall effect of a patient’s hereditary risk factors on disease severity has so far not been studied. We therefore assessed the relationship between high genetic risk and development of organ damage in SLE.Methods: Patients with SLE, who met at least 4 ACR criteria (n = 1012), were genotyped using a 200K Immunochip SNP Array (Illumina). A genetic risk score (GRS) was assigned to each patient based on the single nucleotide polymorphisms (SNPs) which in previous studies have shown association (p<5×10-8) with SLE according to Morris, et al (Nat Genet, 2016. 48(8): p. 940-6). For 32 loci the SLE GWAS SNP was available on the ImmunoChip. For each SNP, the natural logarithm of the odds ratio (OR) for SLE susceptibility was multiplied by the number of risk alleles in each individual. The sum of all products for each patient was defined as the GRS. Information regarding organ damage according to Systemic Lupus International Collaborating Clinics / American College of Rheumatology Damage Index (SLICC-DI), disease manifestations, antibody profile, medication, current disease activity, age at diagnosis and sex was retrieved from medical records. Statistical analyzes were performed using Statistica 13.2 (Statsoft).Results: In an ordinal regression model, with SLICC-DI (0, 1, 2, 3, 4 and >4 points) as outcome and age and GRS as independent variables, an association was found between GRS and SLICC-DI (OR1.16 (1.03-1.31), p=0.015). The relationship was more pronounced for patients under 60 years of age (OR1.30 (1.11-1.52) p=7.1×10-4). Using a linear regression model, a negative relationship was observed between GRS and age at diagnosis (β = -0.13, p=1.5×10-5).When analyzing the 11 SLE criteria (ACR-82) using a logistic regression model associations were observed between GRS and nephritis (OR 1.26 (1.09-1.45), p=0.0015), the immunological criteria (OR 1.31 (1.13-1.51), p = 3.2×10-4) and arthritis (OR 0.84 (0.71-1.00), p=0.044). A high GRS was also associated with presence of anti-dsDNA (OR 1.37 (1.15-1.62), p=9.4×10-7) and low complement levels (OR 1.32 (1.03-1.68), p=0.044). No association was observed between GRS and disease activity at the time of follow-up and there was no difference in GRS between men and women with SLE.Conclusion: In patients with SLE, there is an association between a high genetic risk score and early disease onset. In addition, patients with high genetic risk scores have a higher risk of developing permanent organ damage compared to individuals with fewer risk genes. Our findings indicate that genetic profiling of patients with SLE may provide a tool for predicting severity of the disease.
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
|
|
